MT1G and cancer: Activation of NRF2 axis in cancer cells triggers the induction of multiple anti-ferroptotic genes, including SLC7A11, ATP binding cassette subfamily C member 5 (ABCC5), metallothionein 1G (MT1G), FSP1, CBS, and superoxide dismutase 2 (SOD2).